WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcus Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Juan C. JaenPresident2026-01-05100$23.20
$2.32kSell
Juan C. JaenPresident2026-01-052,053$22.34
$45.86kSell
Juan C. JaenPresident2026-01-0529,670$21.34
$633.16kSell
Ii Robert C. GoeltzChief Financial Officer2025-12-316,552$23.38
$153.19kSell
Alexander AzoyChief Accounting Officer2025-12-184,343$22.25
$96.61kSell
Carolyn C. TangGeneral Counsel2025-12-176,810$22.16
$150.91kSell
Ii Robert C. GoeltzChief Financial Officer2025-12-175,960$22.16
$132.07kSell
Juan C. JaenPresident2025-12-179,983$22.16
$221.22kSell
Jennifer JarrettChief Operating Officer2025-12-179,983$22.16
$221.22kSell
Alexander AzoyChief Accounting Officer2025-12-172,113$22.16
$46.82kSell

1 of 4

RCUS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCUS insiders and whales buy or sell their stock.

RCUS Shareholders

What type of owners hold Arcus Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc25.07%31,424,760$690.40MInsider
Gilead Sciences Inc25.07%31,424,760$690.40MInstitution
Blackrock Inc11.96%14,997,891$329.50MInstitution
Terry J. Rosen11.50%14,413,895$316.67MInsider
Vanguard Group Inc6.35%7,962,874$174.94MInstitution
Suvretta Capital Management LLC4.14%5,188,858$114.00MInstitution
Wellington Management Group LLP4.14%5,184,509$113.90MInstitution
State Street Corp3.65%4,576,969$100.56MInstitution
Woodline Partners LP3.01%3,769,788$82.82MInstitution
Marshall Wace LLP2.70%3,387,794$74.43MInstitution

1 of 3

RCUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCUS68.34%31.66%Net SellingNet Selling
ARQT77.27%22.73%Net SellingNet Selling
CPRX84.21%15.79%Net Selling
TLX0.33%0.00%
VERA69.59%30.41%Net BuyingNet Selling
View Top Biotech Stocks

Arcus Biosciences Stock Ownership FAQ

Who owns Arcus Biosciences?

Arcus Biosciences (NYSE: RCUS) is owned by 96.89% institutional shareholders, 44.88% Arcus Biosciences insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcus Biosciences shareholder, owning 31.42M shares representing 25.07% of the company. Gilead Sciences Inc's Arcus Biosciences shares are currently valued at $690.40M.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.